E
Eugene R. Schiff
Researcher at United States Department of Veterans Affairs
Publications - 116
Citations - 11378
Eugene R. Schiff is an academic researcher from United States Department of Veterans Affairs. The author has contributed to research in topics: Hepatitis & Hepatitis B. The author has an hindex of 42, co-authored 116 publications receiving 11172 citations. Previous affiliations of Eugene R. Schiff include University of Miami & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.
Gary L. Davis,Balart La,Eugene R. Schiff,Lindsay K,Bodenheimer Hc,Perrillo Rp,Carey W,Jacobson Im,Payne J,Jules L. Dienstag +9 more
TL;DR: In this article, the authors evaluated the efficacy of interferon alfa therapy for chronic hepatitis C (non-A, non-B hepatitis) and found that it is a common and often progressive viral liver disease.
Journal ArticleDOI
Lamivudine as initial treatment for chronic hepatitis B in the United States.
Jules L. Dienstag,Eugene R. Schiff,Teresa L. Wright,Robert P. Perrillo,Hie-Won L. Hann,Zachary Goodman,Lynn Crowther,Lynn D. Condreay,Mary Woessner,Marc Rubin,Nathaniel A. Brown +10 more
TL;DR: One year of lamivudine therapy had favorable effects on histologic, virologic, and biochemical features of the disease and was well tolerated.
Book
Diseases of the liver
Leon Schiff,Eugene R. Schiff +1 more
TL;DR: This chapter examines Anatomy; Function; Differences between dogs and cats; Investigating liver disease; Pathophysiology of acute and chronic Liver disease; Acute liver disease ; Chronic liver disease%; and Treatment of chronic liver disease.
Journal Article
National Institutes of Health Consensus Development Conference panel statement: Management of hepatitis C
Don W. Powell,B. Z. Abramson,J. A. Balint,Steven H. Belle,J. R. Bloomer,A. K. Diehl,J. T. Frakes,G. Garcia-Tsao,E. W. Hook,J. M. Lusher,M. A. Popovsky,L. Rabeneck,Amy L. Williams,Tommie Sue Tralka,H. J. Alter,Miriam J. Alter,Elsa A. Bray,L. Curtis,Jay E. Everhart,Stephen M. Feinstone,John H. Ferguson,J. S. Gress,William H. Hall,Jay H. Hoofnagle,L. D. Johnson,Thomas F. Kresina,Karen L. Lindsay,Anna S.F. Lok,P. R. McCurdy,Robert P. Perrillo,Robert H. Purcell,Eugene R. Schiff,W. D. Schwieterman,Leonard B. Seeff,C. R. Sherman,M. H. Stolar,A. Trachtenberg +36 more
TL;DR: A responsible assessment of current available methods to diagnose, treat, and manage hepatitis C is provided to provide health care providers, patients, and the general public with a responsible assessment.
Journal ArticleDOI
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
Jules L. Dienstag,Robert P. Perrillo,Eugene R. Schiff,Maria Bartholomew,Catherine A. Vicary,Marc Rubin +5 more
TL;DR: In a preliminary trial, 12 weeks of lamivudine therapy was well tolerated, and daily doses of 100 mg and 300 mg reduced HBV DNA to undetectable levels.